Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression
- J Cancer Res Clin Oncol. 2014 Nov;140(11):1835-48. doi: 10.1007/s00432-014-1723-2.
- 1. Centre for Clinical Laboratory of the Affiliated Hospital, Key Laboratory of Laboratory Medicine of Jiangsu Province, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu, 212001, People's Republic of China.
Purpose: This study was designed to investigate the role of PDGF-DD secreted by gastric cancer-derived mesenchymal stem cells (GC-MSCs) in human Gastric Cancer progression.
Methods: Gastric Cancer cells were indirectly co-cultured with GC-MSCs in a transwell system. The growth and migration of Gastric Cancer cells were evaluated by cell colony formation assay and transwell migration assay, respectively. The production of PDGF-DD in GC-MSCs was determined by using Luminex and ELISA. Neutralization of PDGFR-β by su16f and siRNA interference of PDGF-DD in GC-MSCs was used to demonstrate the role of PDGF-DD produced by GC-MSCs in Gastric Cancer progression.
Results: GC-MSC conditioned medium promoted Gastric Cancer cell proliferation and migration in vitro and in vivo. Co-culture with GC-MSCs increased the phosphorylation of PDGFR-β in SGC-7901 cells. Neutralization of PDGFR-β by su16f blocked the promoting role of GC-MSC conditioned medium in Gastric Cancer cell proliferation and migration. Recombinant PDGF-DD duplicated the effects of GC-MSC conditioned medium on Gastric Cancer cells. Knockdown of PDGF-DD in GC-MSCs abolished its effects on Gastric Cancer cells in vitro and in vivo.
Conclusions: PDGF-DD secreted by GC-MSCs is capable of promoting Gastric Cancer cell progression in vitro and in vivo. Targeting the PDGF-DD/PDGFR-β interaction between MSCs and Gastric Cancer cells may represent a novel strategy for Gastric Cancer therapy.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
Cat. No.Product NameCategory/Application